New Amsterdam Pharma
Naarden
About New Amsterdam Pharma
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $1.2B
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2024)
- Ticker: nasdaq:NAMS
- Website: newamsterdampharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/new-amsterdam-pharma-120529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.